Cargando…

Comprehensive analysis of lncRNAs N(6)-methyladenosine modification in colorectal cancer

Background: Long non-coding RNAs (lncRNAs) and their N6-methyladenosine (M6A) modifications are involved in cancer occurrence and development. Methods: lncRNA M6A modification in colorectal cancer (CRC) was comprehensively analyzed for the first time. Results: M6A levels of lnRNAs in CRC tissues wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuo, Luo, Su, Hui, Zhang, Qiao, Wu, Wei-yu, Zeng, Yan, Li, Xue-mei, Xiong, Jing, Chen, Lan-fang, Zhou, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906145/ https://www.ncbi.nlm.nih.gov/pubmed/33493136 http://dx.doi.org/10.18632/aging.202383

Ejemplares similares

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Novel insights into mutual regulation between N(6)-methyladenosine modification and LncRNAs in tumors
por: Zhang, Nan, et al.
Publicado: (2023)

The Role of N6-Methyladenosine-Associated lncRNAs in the Immune Microenvironment and Prognosis of Colorectal Cancer
por: Yuan, Congfei, et al.
Publicado: (2022)

Construction and Analysis of a Colorectal Cancer Prognostic Model Based on N6-Methyladenosine-Related lncRNAs
por: Zeng, Hanqian, et al.
Publicado: (2021)

Comprehensive analysis of differences of N(6)-methyladenosine of lncRNAs between atrazine-induced and normal Xenopus laevis testis
por: Qi, Xuejie, et al.
Publicado: (2021)

N6-Methyladenosine-Related lncRNAs Are Anticipated Biomarkers for Sarcoma Patients
por: Zhang, Xiaohe, et al.
Publicado: (2022)

Integrated Analysis of N1-Methyladenosine Methylation Regulators-Related lncRNAs in Hepatocellular Carcinoma
por: Song, Danjun, et al.
Publicado: (2023)

Identification of N6-Methyladenosine-Related lncRNAs as a Prognostic Signature in Glioma
por: Chen, Yujia, et al.
Publicado: (2022)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022)

Identification of dysregulated lncRNAs profiling and metastasis‐associated lncRNAs in colorectal cancer by genome‐wide analysis
por: Chen, Yan, et al.
Publicado: (2017)

Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients
por: Wu, Wei Jun, et al.
Publicado: (2023)

Prognostic Value of N6-Methyladenosine-Related lncRNAs in Early-Stage Colorectal Cancer: Association With Immune Cell Infiltration and Chemotherapeutic Drug Sensitivity
por: Xiong, Zhizhong, et al.
Publicado: (2021)

Comprehensive analysis of microarray expression profiles of circRNAs and lncRNAs with associated co-expression networks in human colorectal cancer
por: Tian, Yan, et al.
Publicado: (2018)

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma
por: Wu, Zhongguang, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs is a potential marker for predicting prognosis and immunotherapy in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2022)

Establishment of Prognostic Signatures of N6-Methyladenosine-Related lncRNAs and Their Potential Functions in Hepatocellular Carcinoma Patients
por: Wu, Xianbin, et al.
Publicado: (2022)

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
por: Huang, Ziye, et al.
Publicado: (2022)

Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer
por: Emam, Omnia, et al.
Publicado: (2022)

Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification
por: Gao, Chen, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs as potential biomarkers for predicting prognoses and immune responses in patients with cervical cancer
por: Zhang, He, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

The Risk Correlation between N7-Methylguanosine Modification-Related lncRNAs and Survival Prognosis of Oral Squamous Cell Carcinoma Based on Comprehensive Bioinformatics Analysis
por: Xu, Yanglong, et al.
Publicado: (2022)

Prognosis and Novel Drug Targets for Key lncRNAs of Epigenetic Modification in Colorectal Cancer
por: Zhang, Peng, et al.
Publicado: (2023)

LncRNAs: the bridge linking RNA and colorectal cancer
por: Yang, Yanfei, et al.
Publicado: (2016)

N7-methylguanosine modification of lncRNAs in a rat model of hypoxic pulmonary hypertension: a comprehensive analysis
por: Wang, Huan, et al.
Publicado: (2022)

Comprehensive analysis of serum exosome-derived lncRNAs and mRNAs from patients with rheumatoid arthritis
por: Xue, Li, et al.
Publicado: (2023)

The role of M(6)A modification in the regulation of tumor-related lncRNAs
por: Lan, Yufei, et al.
Publicado: (2021)

Emerging Roles of lncRNAs in the Formation and Progression of Colorectal Cancer
por: He, Qinglian, et al.
Publicado: (2020)

N(6)-Methyladenosine Regulators and Related LncRNAs Are Potential to be Prognostic Markers for Uveal Melanoma and Indicators of Tumor Microenvironment Remodeling
por: Liu, Zhicheng, et al.
Publicado: (2021)

N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients
por: Xu, Shuyu, et al.
Publicado: (2022)

N1-Methyladenosine-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Response in Uterine Corpus Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2022)

miRNAs and lncRNAs in Echinococcus and Echinococcosis
por: He, Zhi, et al.
Publicado: (2020)

Decoding LncRNAs
por: Borkiewicz, Lidia, et al.
Publicado: (2021)

A risk model constructed using 14 N(6)-methyladenosine-related lncRNAs as a new prognostic marker that correlates with the immunomodulatory effect and drug sensitivity in colorectal cancer
por: Huai, Yajun, et al.
Publicado: (2023)

Targeting lncRNAs of colorectal cancers with natural products
por: Sung, Woo Jung, et al.
Publicado: (2023)

Comprehensive Characterization of Common and Cancer-Specific Differently Expressed lncRNAs in Urologic Cancers
por: Yan, You-Ji, et al.
Publicado: (2021)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k6ttgfq6l3nltg8rak76adco79